Phenotypic Profiling of Parents With Cryptic Nonclassic Congenital Adrenal Hyperplasia: Findings in 145 Unrelated Families

March 2011 in “ European journal of endocrinology ”

R. Nandagopal, Ninet Sinaii, Nilo A. Avila, Carol Van Ryzin, Wuyan Chen, Gabriela P. Finkielstain, Sneha P. Mehta, Nazli B. McDonnell, Deborah P. Merke

cryptic nonclassic congenital adrenal hyperplasia NCCAH hirsutism androgenic alopecia glucocorticoid therapy glucocorticoid stress coverage infertility menstrual irregularities nonclassic congenital adrenal hyperplasia hair loss glucocorticoids stress coverage irregular periods

Studysummary This study found that parents identified with cryptic NCCAH through genetic testing are mostly asymptomatic but may experience temporary female infertility and require glucocorticoid stress coverage in specific circumstances.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on academic.oup.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Androgen Excess in Women: Experience with Over 1000 Consecutive Patients

947 citations , February 2004 in “The Journal of Clinical Endocrinology and Metabolism”

In this study, polycystic ovary syndrome was the most prevalent cause of androgen excess, and suppressive hormonal therapy improved hirsutism, menstrual dysfunction, and acne in most patients, though side effects were common.

research Screening for 21-Hydroxylase-Deficient Nonclassic Adrenal Hyperplasia Among Hyperandrogenic Women: A Prospective Study

216 citations , November 1999 in “Fertility and Sterility”

This study found that a basal 17-hydroxyprogesterone level is effective for screening nonclassic adrenal hyperplasia in women, with a 4 ng/mL cutoff providing high specificity and positive predictive value.

research Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism

31 citations , February 1997 in “The Journal of Clinical Endocrinology and Metabolism”

This study concluded that heterozygosity for CYP21 mutations is associated with higher mean and free testosterone levels in women but does not significantly increase their risk of developing clinically evident hyperandrogenism.